[1]
|
Scheltens, P., De Strooper, B., Kivipelto, M., et al. (2021) Alzheimer’s Disease. The Lancet, 397, 1577-1590.
https://doi.org/10.1016/S0140-6736(20)32205-4
|
[2]
|
Ren, R., Qi, J., Lin, S., et al. (2022) The China Alzheimer Report 2022. General Psychiatry, 35, e100751.
https://doi.org/10.1136/gpsych-2022-100751
|
[3]
|
杨芙蓉, 凌格, 朱潇旭, 等. 中医理论探析老年期痴呆与抑郁症的相关性[J]. 中华中医药杂志, 2021, 36(3): 1307-1310.
|
[4]
|
邓泽南, 马秋平, 吴彬, 等. 阿尔茨海默病患者情绪障碍管理的最佳证据总结[J]. 中华护理杂志, 2021, 56(11): 1714-1720.
|
[5]
|
Kim, H., Jeong, W., Kwon, J., et al. (2021) Association between Depression and the Risk of Alzheimer’s Disease Using the Korean National Health In-surance Service-Elderly Cohort. Scientific Reports, 11, Article No. 22591.
https://doi.org/10.1038/s41598-021-02201-6
|
[6]
|
普赖斯, D., 张季娅. 洛特卡定律与普赖斯定律[J]. 科学学与科学技术管理, 1984(9): 17-22.
|
[7]
|
Chen, C. (2004) Searching for Intellectual Turning Points: Progressive Knowledge Domain Visualization. Proceedings of the National Academy of Sciences of the United States of America, 101, 5303-5310.
https://doi.org/10.1073/pnas.0307513100
|
[8]
|
Mintzer, J., Lanctôt, K.L., Scherer, R.W., et al. (2021) Effect of Methylphenidate on Apathy in Patients with Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neu-rology, 78, 1324-1332.
https://doi.org/10.1001/jamaneurol.2021.3356
|
[9]
|
Harerimana, N.V., Liu, Y., Gerasimov, E.S., et al. (2022) Ge-netic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease. Biological Psychiatry, 92, 25-33. https://doi.org/10.1016/j.biopsych.2021.11.025
|
[10]
|
Holmes, C., Arranz, M., Collier, D., et al. (2003) Depression in Alzheimer’s Disease: The Effect of Serotonin Receptor Gene Variation. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 119B, 40-43.
https://doi.org/10.1002/ajmg.b.10068
|
[11]
|
Luca, M., Di Mauro, M., Di Mauro, M., et al. (2019) Gut Microbiota in Alzheimer’s Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 4730539. https://doi.org/10.1155/2019/4730539
|
[12]
|
Lin, L., Zheng, L.J. and Zhang, L.J. (2018) Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease. Molecular Neurobiology, 55, 8243-8250. https://doi.org/10.1007/s12035-018-0983-2
|
[13]
|
Silva, M.V.F., Loures, C.M.G., Alves, L.C.V., et al. (2019) Alzheimer’s Disease: Risk Factors and Potentially Protective Measures. Journal of Biomedical Science, 26, Arti-cle No. 33. https://doi.org/10.1186/s12929-019-0524-y
|
[14]
|
Muntsant, A. and Giménez-Llort, L. (2022) Crosstalk of Alzheimer’s Disease-Phenotype, HPA Axis, Splenic Oxidative Stress and Frailty in Late-Stages of Dementia, with Special Concerns on the Effects of Social Isolation: A Translational Neuroscience Approach. Frontiers in Aging Neuro-science, 14, Article 969381.
https://doi.org/10.3389/fnagi.2022.969381
|
[15]
|
Dolotov, O.V., Inozemtseva, L.S., Myasoedov, N.F., et al. (2022) Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes. International Journal of Molecular Sciences, 23, Article 4999.
https://doi.org/10.3390/ijms23094999
|
[16]
|
Wenzler, S., et al. (2017) Integrated Biomarkers for Depression in Alz-heimer’s Disease: A Critical Review. Current Alzheimer Research, 14, 441-452. https://doi.org/10.2174/1567205013666160603011256
|
[17]
|
Galts, C.P.C., Bettio, L.E.B., Jewett, D.C., et al. (2019) Depression in Neurodegenerative Diseases: Common Mechanisms and Current Treatment Options. Neuroscience and Biobehavioral Reviews, 102, 56-84.
https://doi.org/10.1016/j.neubiorev.2019.04.002
|
[18]
|
Leszek, J., Mikhaylenko, E.V., Belousov, D.M., et al. (2021) The Links between Cardiovascular Diseases and Alzheimer’s Disease. Current Neuropharmacology, 19, 152-169. https://doi.org/10.2174/18756190MTA4dNjE52
|
[19]
|
Kim, D., Wang, R., Kiss, A., et al. (2021) Depression and Increased Risk of Alzheimer’s Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors. The American Journal of Geriatric Psychiatry, 29, 917-926.
https://doi.org/10.1016/j.jagp.2020.12.031
|
[20]
|
Schliep, K.C., Barbeau, W.A., Lynch, K.E., et al. (2022) Overall and Sex-Specific Risk Factors for Subjective Cognitive Decline: Findings from the 2015-2018 Behavioral Risk Factor Surveillance System Survey. Biology of Sex Differences, 13, Article No. 16. https://doi.org/10.1186/s13293-022-00425-3
|
[21]
|
Billioti de Gage, S., Moride, Y., Ducruet, T., et al. (2014) Ben-zodiazepine Use and Risk of Alzheimer’s Disease: Case-Control Study. BMJ, 349, g5205. https://doi.org/10.1136/bmj.g5205
|
[22]
|
Jia, L., Du, Y., Chu, L., et al. (2020) Prevalence, Risk Factors, and Man-agement of Dementia and Mild Cognitive Impairment in Adults Aged 60 Years or Older in China: A Cross-Sectional Study. The Lancet Public Health, 5, e661-e671. https://doi.org/10.1016/S2468-2667(20)30185-7
|
[23]
|
Morgese, M.G. and Trabace, L. (2019) Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint? Frontiers in Pharmacology, 10, Article 483. https://doi.org/10.3389/fphar.2019.00483
|
[24]
|
Yan, Z. and Rein, B. (2022) Mechanisms of Synaptic Transmission Dysregulation in the Prefrontal Cortex: Pathophysiological Implications. Molecular Psychiatry, 27, 445-465. https://doi.org/10.1038/s41380-021-01092-3
|
[25]
|
Kułak-Bejda, A., Bejda, G. and Waszkiewicz, N. (2021) Mental Disorders, Cognitive Impairment and the Risk of Suicide in Older Adults. Frontiers in Psychiatry, 12, Article 695286. https://doi.org/10.3389/fpsyt.2021.695286
|
[26]
|
Winer, J.R., Deters, K.D., Kennedy, G., et al. (2021) Association of Short and Long Sleep Duration with Amyloid-β Burden and Cognition in Aging. JAMA Neurology, 78, 1187-1196. https://doi.org/10.1001/jamaneurol.2021.2876
|
[27]
|
Elsworthy, R.J. and Aldred, S. (2019) Depression in Alz-heimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors? Journal of Alzheimer’s Disease, 69, 651-661. https://doi.org/10.3233/JAD-180780
|
[28]
|
Huang, M., Liang, Y., Chen, H., et al. (2018) The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model. Frontiers in Aging Neuroscience, 10, Article 164.
https://doi.org/10.3389/fnagi.2018.00164
|
[29]
|
Banerjee, S., Hellier, J., Romeo, R., et al. (2013) Study of the Use of Antidepressants for Depression in Dementia: The HTA-SADD Trial—A Multicentre, Randomised, Double-Blind, Pla-cebo-Controlled Trial of the Clinical Effectiveness and Cost-Effectiveness of Sertraline and Mirtazapine. Health Tech-nology Assessment, 17, 1-166.
https://doi.org/10.3310/hta17070
|
[30]
|
Luan, X., Tian, X., Zhang, H., et al. (2019) Exercise as a Prescription for Pa-tients with Various Diseases. Journal of Sport and Health Science, 8, 422-441. https://doi.org/10.1016/j.jshs.2019.04.002
|
[31]
|
Burke, M.J., Fried, P.J. and Pascual-Leone, A. (2019) Transcranial Magnetic Stimulation: Neurophysiological and Clinical Applications. Handbook of Clinical Neurology, 163, 73-92.
https://doi.org/10.1016/B978-0-12-804281-6.00005-7
|